Drug Profile
Desmethoxystreptonigrin
Latest Information Update: 28 Feb 1996
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Antibacterials; Antineoplastics; Heterocyclic acids; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Cancer
Most Recent Events
- 28 Feb 1996 Discontinued-Preclinical for Cancer in USA (Unknown route)
- 24 Jul 1995 Discontinued-Preclinical for Bacterial infections in USA (Unknown route)